Kidney Cancer Diagnostics Market, Global Outlook and Forecast 2022-2028

July 2024 | 71 pages | ID: KD1A7F2DC60CEN
Market Monitor Global

Abstracts

Kidney cancer is a type of cancer which starts in kidney cells. Two major types of kidney cancer include transitional cell carcinoma (TCC) and renal cell carcinoma (RCC). Different types of kidney cancer get developed in different ways which imply different long-term outcomes.

This report contains market size and forecasts of Kidney Cancer Diagnostics in global, including the following market information:

Global Kidney Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Kidney Cancer Diagnostics Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Kidney Cancer Diagnostics companies in 2021 (%)

The global Kidney Cancer Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Immunohistochemistry Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Kidney Cancer Diagnostics include Thermo Fisher Scientific, Abbott Laboratories, Illumina, Quest Diagnostics Incorporated, Roche Holding, Myriad Genetics, NeoGenomics Laboratories, NanoString Technologies and Sysmex Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Kidney Cancer Diagnostics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Kidney Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Kidney Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)

• Immunohistochemistry
• Urine Analysis
• Blood Chemistry Test
• Others

Global Kidney Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Kidney Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics
• Others

Global Kidney Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Kidney Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Kidney Cancer Diagnostics revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Kidney Cancer Diagnostics revenues share in global market, 2021 (%)

Key companies Kidney Cancer Diagnostics sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Kidney Cancer Diagnostics sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Abbott Laboratories
• Illumina
• Quest Diagnostics Incorporated
• Roche Holding
• Myriad Genetics
• NeoGenomics Laboratories
• NanoString Technologies
• Sysmex Corporation
• Rosetta Genomics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Kidney Cancer Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Kidney Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL KIDNEY CANCER DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Kidney Cancer Diagnostics Market Size: 2021 VS 2028
2.2 Global Kidney Cancer Diagnostics Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Kidney Cancer Diagnostics Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Kidney Cancer Diagnostics Players in Global Market
3.2 Top Global Kidney Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Kidney Cancer Diagnostics Revenue by Companies
3.4 Global Kidney Cancer Diagnostics Sales by Companies
3.5 Global Kidney Cancer Diagnostics Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Kidney Cancer Diagnostics Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Kidney Cancer Diagnostics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kidney Cancer Diagnostics Players in Global Market
  3.8.1 List of Global Tier 1 Kidney Cancer Diagnostics Companies
  3.8.2 List of Global Tier 2 and Tier 3 Kidney Cancer Diagnostics Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Kidney Cancer Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 Immunohistochemistry
  4.1.3 Urine Analysis
  4.1.4 Blood Chemistry Test
  4.1.5 Others
4.2 By Type - Global Kidney Cancer Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Kidney Cancer Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Kidney Cancer Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
4.3 By Type - Global Kidney Cancer Diagnostics Sales & Forecasts
  4.3.1 By Type - Global Kidney Cancer Diagnostics Sales, 2017-2022
  4.3.2 By Type - Global Kidney Cancer Diagnostics Sales, 2023-2028
  4.3.3 By Type - Global Kidney Cancer Diagnostics Sales Market Share, 2017-2028
4.4 By Type - Global Kidney Cancer Diagnostics Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Kidney Cancer Diagnostics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
  5.1.4 Others
5.2 By Application - Global Kidney Cancer Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Kidney Cancer Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Kidney Cancer Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
5.3 By Application - Global Kidney Cancer Diagnostics Sales & Forecasts
  5.3.1 By Application - Global Kidney Cancer Diagnostics Sales, 2017-2022
  5.3.2 By Application - Global Kidney Cancer Diagnostics Sales, 2023-2028
  5.3.3 By Application - Global Kidney Cancer Diagnostics Sales Market Share, 2017-2028
5.4 By Application - Global Kidney Cancer Diagnostics Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Kidney Cancer Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Kidney Cancer Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Kidney Cancer Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Kidney Cancer Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
6.3 By Region - Global Kidney Cancer Diagnostics Sales & Forecasts
  6.3.1 By Region - Global Kidney Cancer Diagnostics Sales, 2017-2022
  6.3.2 By Region - Global Kidney Cancer Diagnostics Sales, 2023-2028
  6.3.3 By Region - Global Kidney Cancer Diagnostics Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Kidney Cancer Diagnostics Revenue, 2017-2028
  6.4.2 By Country - North America Kidney Cancer Diagnostics Sales, 2017-2028
  6.4.3 US Kidney Cancer Diagnostics Market Size, 2017-2028
  6.4.4 Canada Kidney Cancer Diagnostics Market Size, 2017-2028
  6.4.5 Mexico Kidney Cancer Diagnostics Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Kidney Cancer Diagnostics Revenue, 2017-2028
  6.5.2 By Country - Europe Kidney Cancer Diagnostics Sales, 2017-2028
  6.5.3 Germany Kidney Cancer Diagnostics Market Size, 2017-2028
  6.5.4 France Kidney Cancer Diagnostics Market Size, 2017-2028
  6.5.5 U.K. Kidney Cancer Diagnostics Market Size, 2017-2028
  6.5.6 Italy Kidney Cancer Diagnostics Market Size, 2017-2028
  6.5.7 Russia Kidney Cancer Diagnostics Market Size, 2017-2028
  6.5.8 Nordic Countries Kidney Cancer Diagnostics Market Size, 2017-2028
  6.5.9 Benelux Kidney Cancer Diagnostics Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Kidney Cancer Diagnostics Revenue, 2017-2028
  6.6.2 By Region - Asia Kidney Cancer Diagnostics Sales, 2017-2028
  6.6.3 China Kidney Cancer Diagnostics Market Size, 2017-2028
  6.6.4 Japan Kidney Cancer Diagnostics Market Size, 2017-2028
  6.6.5 South Korea Kidney Cancer Diagnostics Market Size, 2017-2028
  6.6.6 Southeast Asia Kidney Cancer Diagnostics Market Size, 2017-2028
  6.6.7 India Kidney Cancer Diagnostics Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Kidney Cancer Diagnostics Revenue, 2017-2028
  6.7.2 By Country - South America Kidney Cancer Diagnostics Sales, 2017-2028
  6.7.3 Brazil Kidney Cancer Diagnostics Market Size, 2017-2028
  6.7.4 Argentina Kidney Cancer Diagnostics Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Kidney Cancer Diagnostics Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Kidney Cancer Diagnostics Sales, 2017-2028
  6.8.3 Turkey Kidney Cancer Diagnostics Market Size, 2017-2028
  6.8.4 Israel Kidney Cancer Diagnostics Market Size, 2017-2028
  6.8.5 Saudi Arabia Kidney Cancer Diagnostics Market Size, 2017-2028
  6.8.6 UAE Kidney Cancer Diagnostics Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific Kidney Cancer Diagnostics Major Product Offerings
  7.1.4 Thermo Fisher Scientific Kidney Cancer Diagnostics Sales and Revenue in Global (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 Abbott Laboratories
  7.2.1 Abbott Laboratories Corporate Summary
  7.2.2 Abbott Laboratories Business Overview
  7.2.3 Abbott Laboratories Kidney Cancer Diagnostics Major Product Offerings
  7.2.4 Abbott Laboratories Kidney Cancer Diagnostics Sales and Revenue in Global (2017-2022)
  7.2.5 Abbott Laboratories Key News
7.3 Illumina
  7.3.1 Illumina Corporate Summary
  7.3.2 Illumina Business Overview
  7.3.3 Illumina Kidney Cancer Diagnostics Major Product Offerings
  7.3.4 Illumina Kidney Cancer Diagnostics Sales and Revenue in Global (2017-2022)
  7.3.5 Illumina Key News
7.4 Quest Diagnostics Incorporated
  7.4.1 Quest Diagnostics Incorporated Corporate Summary
  7.4.2 Quest Diagnostics Incorporated Business Overview
  7.4.3 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Major Product Offerings
  7.4.4 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales and Revenue in Global (2017-2022)
  7.4.5 Quest Diagnostics Incorporated Key News
7.5 Roche Holding
  7.5.1 Roche Holding Corporate Summary
  7.5.2 Roche Holding Business Overview
  7.5.3 Roche Holding Kidney Cancer Diagnostics Major Product Offerings
  7.5.4 Roche Holding Kidney Cancer Diagnostics Sales and Revenue in Global (2017-2022)
  7.5.5 Roche Holding Key News
7.6 Myriad Genetics
  7.6.1 Myriad Genetics Corporate Summary
  7.6.2 Myriad Genetics Business Overview
  7.6.3 Myriad Genetics Kidney Cancer Diagnostics Major Product Offerings
  7.6.4 Myriad Genetics Kidney Cancer Diagnostics Sales and Revenue in Global (2017-2022)
  7.6.5 Myriad Genetics Key News
7.7 NeoGenomics Laboratories
  7.7.1 NeoGenomics Laboratories Corporate Summary
  7.7.2 NeoGenomics Laboratories Business Overview
  7.7.3 NeoGenomics Laboratories Kidney Cancer Diagnostics Major Product Offerings
  7.7.4 NeoGenomics Laboratories Kidney Cancer Diagnostics Sales and Revenue in Global (2017-2022)
  7.7.5 NeoGenomics Laboratories Key News
7.8 NanoString Technologies
  7.8.1 NanoString Technologies Corporate Summary
  7.8.2 NanoString Technologies Business Overview
  7.8.3 NanoString Technologies Kidney Cancer Diagnostics Major Product Offerings
  7.8.4 NanoString Technologies Kidney Cancer Diagnostics Sales and Revenue in Global (2017-2022)
  7.8.5 NanoString Technologies Key News
7.9 Sysmex Corporation
  7.9.1 Sysmex Corporation Corporate Summary
  7.9.2 Sysmex Corporation Business Overview
  7.9.3 Sysmex Corporation Kidney Cancer Diagnostics Major Product Offerings
  7.9.4 Sysmex Corporation Kidney Cancer Diagnostics Sales and Revenue in Global (2017-2022)
  7.9.5 Sysmex Corporation Key News
7.10 Rosetta Genomics
  7.10.1 Rosetta Genomics Corporate Summary
  7.10.2 Rosetta Genomics Business Overview
  7.10.3 Rosetta Genomics Kidney Cancer Diagnostics Major Product Offerings
  7.10.4 Rosetta Genomics Kidney Cancer Diagnostics Sales and Revenue in Global (2017-2022)
  7.10.5 Rosetta Genomics Key News

8 GLOBAL KIDNEY CANCER DIAGNOSTICS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Kidney Cancer Diagnostics Production Capacity, 2017-2028
8.2 Kidney Cancer Diagnostics Production Capacity of Key Manufacturers in Global Market
8.3 Global Kidney Cancer Diagnostics Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 KIDNEY CANCER DIAGNOSTICS SUPPLY CHAIN ANALYSIS

10.1 Kidney Cancer Diagnostics Industry Value Chain
10.2 Kidney Cancer Diagnostics Upstream Market
10.3 Kidney Cancer Diagnostics Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Kidney Cancer Diagnostics Distributors and Sales Agents in Global

11 CONCLUSION


12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Kidney Cancer Diagnostics in Global Market
Table 2. Top Kidney Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Kidney Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Kidney Cancer Diagnostics Revenue Share by Companies, 2017-2022
Table 5. Global Kidney Cancer Diagnostics Sales by Companies, (K Units), 2017-2022
Table 6. Global Kidney Cancer Diagnostics Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Kidney Cancer Diagnostics Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Kidney Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Kidney Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Kidney Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Kidney Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Kidney Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Kidney Cancer Diagnostics Sales (K Units), 2017-2022
Table 15. By Type - Global Kidney Cancer Diagnostics Sales (K Units), 2023-2028
Table 16. By Application – Global Kidney Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Kidney Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Kidney Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Kidney Cancer Diagnostics Sales (K Units), 2017-2022
Table 20. By Application - Global Kidney Cancer Diagnostics Sales (K Units), 2023-2028
Table 21. By Region – Global Kidney Cancer Diagnostics Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Kidney Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Kidney Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Kidney Cancer Diagnostics Sales (K Units), 2017-2022
Table 25. By Region - Global Kidney Cancer Diagnostics Sales (K Units), 2023-2028
Table 26. By Country - North America Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Kidney Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Kidney Cancer Diagnostics Sales, (K Units), 2017-2022
Table 29. By Country - North America Kidney Cancer Diagnostics Sales, (K Units), 2023-2028
Table 30. By Country - Europe Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Kidney Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Kidney Cancer Diagnostics Sales, (K Units), 2017-2022
Table 33. By Country - Europe Kidney Cancer Diagnostics Sales, (K Units), 2023-2028
Table 34. By Region - Asia Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Kidney Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Kidney Cancer Diagnostics Sales, (K Units), 2017-2022
Table 37. By Region - Asia Kidney Cancer Diagnostics Sales, (K Units), 2023-2028
Table 38. By Country - South America Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Kidney Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Kidney Cancer Diagnostics Sales, (K Units), 2017-2022
Table 41. By Country - South America Kidney Cancer Diagnostics Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Kidney Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Kidney Cancer Diagnostics Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Kidney Cancer Diagnostics Sales, (K Units), 2023-2028
Table 46. Thermo Fisher Scientific Corporate Summary
Table 47. Thermo Fisher Scientific Kidney Cancer Diagnostics Product Offerings
Table 48. Thermo Fisher Scientific Kidney Cancer Diagnostics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Abbott Laboratories Corporate Summary
Table 50. Abbott Laboratories Kidney Cancer Diagnostics Product Offerings
Table 51. Abbott Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Illumina Corporate Summary
Table 53. Illumina Kidney Cancer Diagnostics Product Offerings
Table 54. Illumina Kidney Cancer Diagnostics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Quest Diagnostics Incorporated Corporate Summary
Table 56. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product Offerings
Table 57. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Roche Holding Corporate Summary
Table 59. Roche Holding Kidney Cancer Diagnostics Product Offerings
Table 60. Roche Holding Kidney Cancer Diagnostics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Myriad Genetics Corporate Summary
Table 62. Myriad Genetics Kidney Cancer Diagnostics Product Offerings
Table 63. Myriad Genetics Kidney Cancer Diagnostics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. NeoGenomics Laboratories Corporate Summary
Table 65. NeoGenomics Laboratories Kidney Cancer Diagnostics Product Offerings
Table 66. NeoGenomics Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. NanoString Technologies Corporate Summary
Table 68. NanoString Technologies Kidney Cancer Diagnostics Product Offerings
Table 69. NanoString Technologies Kidney Cancer Diagnostics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Sysmex Corporation Corporate Summary
Table 71. Sysmex Corporation Kidney Cancer Diagnostics Product Offerings
Table 72. Sysmex Corporation Kidney Cancer Diagnostics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Rosetta Genomics Corporate Summary
Table 74. Rosetta Genomics Kidney Cancer Diagnostics Product Offerings
Table 75. Rosetta Genomics Kidney Cancer Diagnostics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Kidney Cancer Diagnostics Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Kidney Cancer Diagnostics Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Kidney Cancer Diagnostics Production by Region, 2017-2022 (K Units)
Table 79. Global Kidney Cancer Diagnostics Production by Region, 2023-2028 (K Units)
Table 80. Kidney Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 81. Kidney Cancer Diagnostics Market Drivers in Global Market
Table 82. Kidney Cancer Diagnostics Market Restraints in Global Market
Table 83. Kidney Cancer Diagnostics Raw Materials
Table 84. Kidney Cancer Diagnostics Raw Materials Suppliers in Global Market
Table 85. Typical Kidney Cancer Diagnostics Downstream
Table 86. Kidney Cancer Diagnostics Downstream Clients in Global Market
Table 87. Kidney Cancer Diagnostics Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Kidney Cancer Diagnostics Segment by Type
Figure 2. Kidney Cancer Diagnostics Segment by Application
Figure 3. Global Kidney Cancer Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Kidney Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Kidney Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. Kidney Cancer Diagnostics Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Kidney Cancer Diagnostics Revenue in 2021
Figure 9. By Type - Global Kidney Cancer Diagnostics Sales Market Share, 2017-2028
Figure 10. By Type - Global Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Type - Global Kidney Cancer Diagnostics Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Kidney Cancer Diagnostics Sales Market Share, 2017-2028
Figure 13. By Application - Global Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 14. By Application - Global Kidney Cancer Diagnostics Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Kidney Cancer Diagnostics Sales Market Share, 2017-2028
Figure 16. By Region - Global Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 17. By Country - North America Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 18. By Country - North America Kidney Cancer Diagnostics Sales Market Share, 2017-2028
Figure 19. US Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Kidney Cancer Diagnostics Sales Market Share, 2017-2028
Figure 24. Germany Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. France Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Kidney Cancer Diagnostics Sales Market Share, 2017-2028
Figure 33. China Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. India Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 39. By Country - South America Kidney Cancer Diagnostics Sales Market Share, 2017-2028
Figure 40. Brazil Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Kidney Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Kidney Cancer Diagnostics Sales Market Share, 2017-2028
Figure 44. Turkey Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Kidney Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 48. Global Kidney Cancer Diagnostics Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Kidney Cancer Diagnostics by Region, 2021 VS 2028
Figure 50. Kidney Cancer Diagnostics Industry Value Chain
Figure 51. Marketing Channels